LiqTech International, Inc. LIQT 深 滬
等待開盤 08-12 09:30:00 美东时间
1.90
-0.030
-1.55%
華盛通- 最 高2.0771
- 今 開2.00
- 成交量 3531股
- 最 低 1.90
- 昨 收 1.93
- 總市值 1826.66万
- 52周最高 3.20
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.34
- 委 比 -15.66%
- 總股本 961.40万
- 歷史最高 158.40
- 量 比 0.35
- 振 幅 9.18%
- 歷史最低 1.34
- 每 手 1
- 風險率 0.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Liqtech Internationa Announces It Has Received An Order For Delivery Of An Advanced Membrane-Based Filtration System To Treat Oily Wastewater From North Star Bluescope Steel
LiqTech International, Inc. (NASDAQ:LIQT), a leading clean technology company that manufactures and markets highly specialized filtration technologies, today announced it has received an order for the delivery of an
06-25 21:04
LiqTech Advanced Oily Wastewater Filtration Selected by North Star BlueScope Steel
LiqTech International, Inc. announced it received an order from North Star BlueScope Steel for an advanced membrane-based filtration system to treat oily wastewater. The system, utilizing LiqTech’s Silicon Carbide (SiC) membrane technology, addresses filtration challenges caused by high oil content and varying wastewater quality. Scheduled for delivery in the second half of 2025, the system will enhance water recovery efficiency and support North...
06-25 13:00
美股大行评级 | 超配！Hinge Health获多家大行首予评级； Oppenheimer上调Mate目标价从665美元升至775美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持SurgePays Inc(SURG)"买入"评级，目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital：维持LiqTech Internatio
06-17 09:46
Ascendiant Capital Maintains Buy on LiqTech International, Raises Price Target to $3.6
Ascendiant Capital analyst Lucas Ward maintains LiqTech International (NASDAQ:LIQT) with a Buy and raises the price target from $3.4 to $3.6.
06-16 18:36
LiqTech International Sees Q2 Sales $4.800M-$5.200M vs $4.70M Est
LiqTech International (NASDAQ:LIQT) sees Q2 sales of $4.800 million-$5.200 million vs $4.70 million analyst estimate.
05-14 20:02
LiqTech Intl Q1 EPS $(0.25) Misses $(0.18) Estimate, Sales $4.62M Beat $4.50M Estimate
LiqTech Intl (NASDAQ:LIQT) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.18) by 38.89 percent. This is a 24.24 percent increase over losses of $(0.33) per share from
05-14 20:01
快讯 | LiqTech International 宣布2025年第一季度财务结果
LiqTech International Announces First Quarter 2025 Financial Results
05-14 20:00
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
LiqTech International Signs Agreements With NAF Aquatics For U.S. Commercial Swimming Pool Market
he partnership will help LiqTech:Accelerate revenue growth through U.S. market entry.Expand recurring revenue opportunities via long-term system installations.Strengthen its position as a leader in sustainable water
05-13 21:02
美股大行评级 | 潜在涨幅102.31%！瑞穗上调Amylyx制药目标价至7美元，评级升至"跑赢大市"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116286800185102336.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 瑞穗：上调Amylyx Pharmaceuticals(AMLX)评级至"跑赢大市"，目标价从3美元升至7美元</p> <p>• Redburn Atlantic：上调Roku(ROKU)评级至"买入"，目标价100美元<
04-08 10:08
